$121 Billion Worldwide Cytokine Industry to 2027

The "Cytokine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

DUBLIN, Jan. 10, 2023 /PRNewswire/ -- The "Cytokine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to  ResearchAndMarkets.com's offering.

The global cytokine market reached a value of US$ 76.67 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 121.25 Billion by 2027, exhibiting a CAGR of 7.94% during 2021-2027.

Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor. A cytokine refers to a group of proteins, peptides, or glycoproteins released by specific cells to control the growth and activity of the immune system and blood cells. It can regulate immunity, inflammation, and hematopoiesis on account of its high-affinity picomolar concentrations. It is usually injected under the skin or into muscles or veins to help prevent or manage chemotherapy side effects and treat cancer. It also boosts anti-cancer activities by sending signals that make abnormal cells die and normal cells live longer. Presently, it is gaining widespread adoption in cell and gene therapy for the expansion and differentiation of various cell types, ex vivo cultures, and other therapeutic approaches.The coronavirus disease (COVID-19) is transmitted via droplets that can induce the excessive production of proinflammatory cytokines and lead to acute respiratory distress syndrome (ARDS) aggravation and tissue damage. As tissue damage can result in multi-organ failure and death, there is a rise in the demand for solutions that target cytokines to manage patients, improve survival rates, and reduce mortality.

Apart from this, the increasing prevalence of cancer, in confluence with the escalating demand for minimally invasive surgeries (MIS) that provide less post-operative pain and complications and faster recovery time, is contributing to the market growth.

Moreover, as cytokines act as diagnostic, prognostic, and therapeutic agents and biomarkers for health and diseases, they are gaining traction in diverse functions, including immune cell differentiation, inflammation, angiogenesis, tumorigenesis, neurobiology, and viral pathogenesis. Besides this, the rising cases of atopic dermatitis (AD), a recurrent, chronic, and inflammatory skin disease that processes with severe itchiness, is driving the demand for new cytokines in the pathogenesis of AD and developing improved therapeutic targets.

Competitive Landscape:The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Abcam plc, Amgen Inc., Applied Biological Materials Inc. (abm), Bio-Techne Corporation, F. Hoffmann-La Roche AG, GenScript Biotech Corporation, Randox Laboratories Ltd., Thermo Fisher Scientific Inc. and UCB S.A.Key Questions Answered in This Report:

How has the global cytokine market performed so far and how will it perform in the coming years?

What has been the impact of COVID-19 on the global cytokine market?

What are the key regional markets?

What is the breakup of the market based on the cytokine type?

What is the breakup of the market based on the therapeutic application?

What is the breakup of the market based on the end user?

What are the various stages in the value chain of the industry?

What are the key driving factors and challenges in the industry?

What is the structure of the global cytokine market and who are the key players?

What is the degree of competition in the industry?

Key Topics Covered: 1 Preface2 Scope and Methodology3 Executive Summary4 Introduction4.1 Overview4.2 Key Industry Trends5 Global Cytokine Market5.1 Market Overview5.2 Market Performance5.3 Impact of COVID-195.4 Market Forecast6 Market Breakup by Cytokine Type6.1 Tumor Necrosis Factor-TNF6.1.1 Market Trends6.1.2 Market Forecast6.2 Interleukins-Il6.2.1 Market Trends6.2.2 Market Forecast6.3 Interferons-IFN6.3.1 Market Trends6.3.2 Market Forecast6.4 Epidermal Growth Factor-EGF6.4.1 Market Trends6.4.2 Market Forecast6.5 Others6.5.1 Market Trends6.5.2 Market Forecast7 Market Breakup by Therapeutic Application7.1 Cancer7.1.1 Market Trends7.1.2 Market Forecast7.2 Asthma and Airway Inflammation7.2.1 Market Trends7.2.2 Market Forecast7.3 Arthritis7.3.1 Market Trends7.3.2 Market Forecast7.4 Others7.4.1 Market Trends7.4.2 Market Forecast8 Market Breakup by End User8.1 Pharmaceutical and Biotechnology Companies8.1.1 Market Trends8.1.2 Market Forecast8.2 Contract Research Organizations8.2.1 Market Trends8.2.2 Market Forecast8.3 Academic and Research Institutes8.3.1 Market Trends8.3.2 Market Forecast9 Market Breakup by Region10 SWOT Analysis11 Value Chain Analysis12 Porters Five Forces Analysis13 Price Analysis14 Competitive Landscape14.1 Market Structure14.2 Key Players14.3 Profiles of Key Players14.3.1 AbbVie Inc. Company Overview14.3.1.2 Product Portfolio14.3.1.3 Financials14.3.1.4 SWOT Analysis14.3.2 Abcam plc14.3.2.1 Company Overview14.3.2.2 Product Portfolio14.3.2.3 Financials14.3.2.4 SWOT Analysis14.3.3 Amgen Inc. Company Overview14.3.3.2 Product Portfolio14.3.3.3 Financials14.3.4 Applied Biological Materials Inc. (abm) Company Overview14.3.4.2 Product Portfolio14.3.5 Bio-Techne Corporation14.3.5.1 Company Overview14.3.5.2 Product Portfolio14.3.5.3 Financials14.3.6 F. Hoffmann-La Roche AG14.3.6.1 Company Overview14.3.6.2 Product Portfolio14.3.6.3 Financials14.3.7 GenScript Biotech Corporation14.3.7.1 Company Overview14.3.7.2 Product Portfolio14.3.8 Randox Laboratories Ltd. Company Overview14.3.8.2 Product Portfolio14.3.9 Thermo Fisher Scientific Inc. Company Overview14.3.9.2 Product Portfolio14.3.9.3 Financials14.3.9.4 SWOT Analysis14.3.10 UCB S.A. Company Overview14.3.10.2 Product Portfolio14.3.10.3 Financials

For more information about this report visit URL

Media Contact:

Research and MarketsLaura Wood, Senior EMAIL

For E.S.T Office Hours Call +1-917-300-0470For U.S./CAN Toll Free Call +1-800-526-8630For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716

Logo: URL.jpg

View original content:URL.html

SOURCE Research and Markets